Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Psoralen photochemotherapy.

A K Gupta1, T F Anderson

  • 1Department of Dermatology, University of Michigan Medical School, Ann Arbor.

Journal of the American Academy of Dermatology
|November 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peripheral edema due to nifedipine-itraconazole interaction: a case report.

Archives of dermatology·1996
Same author

High frequency 40-MHz ultrasound. A possible noninvasive method for the assessment of the boundary of basal cell carcinomas.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·1996
Same author

Effect of ionizing radiation on AP-1 binding activity and basic fibroblast growth factor gene expression in drug-sensitive human breast carcinoma MCF-7 and multidrug-resistant MCF-7/ADR cells.

The Journal of biological chemistry·1995
Same author

Role of cellular casein kinase II in the function of the phosphoprotein (P) subunit of RNA polymerase of vesicular stomatitis virus.

The Journal of biological chemistry·1995
Same author

Fundus imaging in patients with cataract: role for a variable wavelength scanning laser ophthalmoscope.

The British journal of ophthalmology·1995
Same author

Age and gender differences in the impact of psoriasis on quality of life.

International journal of dermatology·1995
Same journal

Sexual function is missing from the adverse-effect map of GLP-1 receptor agonists in dermatology.

Journal of the American Academy of Dermatology·2026
Same journal

Comparative risk of reactivation of hepatitis B and C after treatment with biologics and targeted synthetic DMARDs in psoriasis and psoriatic arthritis: a 15-year multicenter cohort study.

Journal of the American Academy of Dermatology·2026
Same journal

Safety of Biologic Therapy in Psoriasis Patients With Malignancy.

Journal of the American Academy of Dermatology·2026
Same journal

Letter from the Editor: Glucagon-Like Peptide-1 (GLP-1) agonists in dermatology.

Journal of the American Academy of Dermatology·2026
Same journal

Rethinking the Occipital Scalp as a Control in Advanced Androgenetic Alopecia.

Journal of the American Academy of Dermatology·2026
Same journal

Parallel-Polarized Dermoscopy for Acral Parallel Pattern Analysis.

Journal of the American Academy of Dermatology·2026
See all related articles

Psoralen plus ultraviolet A (PUVA) therapy effectively treats skin conditions like psoriasis and vitiligo. However, long-term use may increase risks such as skin cancer, necessitating careful risk-benefit assessment.

Area of Science:

  • Dermatology
  • Phototherapy

Background:

  • Psoralens and sunlight have historical use in treating vitiligo.
  • Oral psoralen and ultraviolet A (PUVA) therapy, approved in 1982, is effective for severe psoriasis and other skin conditions.

Purpose of the Study:

  • To review the efficacy and side effects of PUVA therapy.
  • To discuss strategies for mitigating long-term adverse effects.

Main Methods:

  • Review of historical and modern use of PUVA therapy.
  • Analysis of reported short-term and long-term side effects.

Main Results:

  • PUVA therapy is effective for various cutaneous conditions with minimal short-term side effects.
  • Long-term risks include squamous cell carcinoma, pigmentation changes, skin aging, and eye abnormalities.

Related Experiment Videos

Conclusions:

  • Careful patient selection and dose limitation can reduce PUVA side effects.
  • Ongoing studies are needed to fully understand long-term risks; individual risk-benefit analysis is crucial.